Search - tctmd.com

Displaying 1 - 20 of 71

Sort: Relevancy | Date

Presentation TCT 2025

ACS Pharma Trials On The Horizon: Antiplatelets Duration and SAPT

Presenter: Marco Valgimigli

October 26, 2025

Presentation TCT 2025

Antithrombotic Therapies in ACS: Choosing Your SAPT For The Long Haul

Presenter: Marco Valgimigli

October 26, 2025

Presentation TCT 2024

Debate Pro: Always

Presenter: Marco Valgimigli

October 30, 2024

Presentation TCT 2024

Sirolimus Coated Balloon Complex Cases Presentations: The TITAN RCT

Presenter: Marco Valgimigli

October 28, 2024

Presentation TCT 2024

Peri-procedural Antithrombotic Management Across Spectrum of CAD Manifestation

Presenter: Marco Valgimigli

October 28, 2024

Presentation TCT 2024

Real-Time Catheter-Based MVO Detection in STEMI: Final Results from the MOCA I Study

Presenter: Marco Valgimigli

October 27, 2024

Presentation TCT 2024

TCT 667: Real-Time Catheter-Based MVO Detection in STEMI: Final Results From the MOCA I Study

Presenter: Marco Valgimigli

October 27, 2024

Presentation TCT 2024

From ARC-HBR and PRECISE-DAPT to PRECISE-2: Development and Validation of a Novel Universal Bleeding Risk Score

Presenter: Marco Valgimigli

October 27, 2024

Presentation TCT 2021

DAPT Duration in High Bleeding Risk Patients: Lessons From RCTs

Presenter: Marco Valgimigli

November 05, 2021

Presentation TCT 2021

Latest HBR Clinical Evidence

Presenter: Marco Valgimigli

November 04, 2021

Presentation JIM 2020

Optimized DES for High ischemic risk & HBR patients: when efficacy and safety converge into one need

Presenter: Marco Valgimigli

February 13, 2020

Presentation TCT 2019

DAPT After PCI With DCB: Current Guidelines and Special Considerations

Presenter: Marco Valgimigli

September 28, 2019

Presentation TCT 2019

Early Experience With CoFI Diagnostic Sequence in Humans

Presenter: Marco Valgimigli

September 27, 2019

Presentation TCT 2019

Reconciling Adjudicated Data Within a Global Trial

Presenter: Marco Valgimigli

September 26, 2019

Presentation TCT 2019

Antithrombotic Therapy in PCI Patients With Atrial Fibrillation

Presenter: Marco Valgimigli

September 25, 2019

Ticagrelor Monotherapy Beyond One Month Versus Conventional Therapy On Adjudicated Ischemic And Bleeding Endpoints Following Drug Eluting Sent Implantation. Primary Results of the GLOBAL LEADERS Adjudication Sub-StudY (GLASSY)

Presentation ACC 2019

Primary Results of the GLOBAL LEADERS Adjudication Sub-StudY (GLASSY)

Presenter: Marco Valgimigli

March 18, 2019

Presentation ESC 2018

The Minimizing Adverse Haemorrhagic Events By Transradial Access Site And Systemic Implementation of Angiox-MATRIX

Presenter: Marco Valgimigli

August 26, 2018

Presentation TCT 2017

SENIOR and Shorter DAPT Studies: Highlights Summary

Presenter: Martin B. Leon, Marco Valgimigli, Olivier Varenne

November 01, 2017

Presentation TCT 2017

CULPRIT-SHOCK: Appreciation and Critique

Presenter: Martin B. Leon, Marco Valgimigli, Cindy L. Grines

November 01, 2017

Presentation TCT 2017

CULPRIT-SHOCK: Highlights Summary

Presenter: Martin B. Leon, Marco Valgimigli, Georg Fuernau, MD

November 01, 2017

Advertisement

ACS Pharma Trials On The Horizon: Antiplatelets Duration and SAPT

Antithrombotic Therapies in ACS: Choosing Your SAPT For The Long Haul

Debate Pro: Always

Sirolimus Coated Balloon Complex Cases Presentations: The TITAN RCT

Peri-procedural Antithrombotic Management Across Spectrum of CAD Manifestation

Real-Time Catheter-Based MVO Detection in STEMI: Final Results from the MOCA I Study

TCT 667: Real-Time Catheter-Based MVO Detection in STEMI: Final Results From the MOCA I Study

From ARC-HBR and PRECISE-DAPT to PRECISE-2: Development and Validation of a Novel Universal Bleeding Risk Score

DAPT Duration in High Bleeding Risk Patients: Lessons From RCTs

Latest HBR Clinical Evidence

Optimized DES for High ischemic risk & HBR patients: when efficacy and safety converge into one need

DAPT After PCI With DCB: Current Guidelines and Special Considerations

Early Experience With CoFI Diagnostic Sequence in Humans

Reconciling Adjudicated Data Within a Global Trial

Antithrombotic Therapy in PCI Patients With Atrial Fibrillation

Primary Results of the GLOBAL LEADERS Adjudication Sub-StudY (GLASSY)

The Minimizing Adverse Haemorrhagic Events By Transradial Access Site And Systemic Implementation of Angiox-MATRIX

SENIOR and Shorter DAPT Studies: Highlights Summary

CULPRIT-SHOCK: Appreciation and Critique

CULPRIT-SHOCK: Highlights Summary

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content